ziprasidone has been researched along with methylcellulose in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caldwell, WB; Sagawa, K; Shah, JC; Thombre, AG | 1 |
| Caldwell, WB; Friesen, DT; McCray, SB; Sutton, SC; Thombre, AG | 1 |
| Chen, G; Ren, L; Wang, J; Xu, X; Xue, X | 1 |
3 other study(ies) available for ziprasidone and methylcellulose
| Article | Year |
|---|---|
In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations.
Topics: Absorption; Acetates; Animals; Antipsychotic Agents; Chemistry, Pharmaceutical; Cyclodextrins; Dogs; Drug Stability; Fasting; Hypromellose Derivatives; Male; Methylcellulose; Nanoparticles; Particle Size; Piperazines; Solubility; Succinic Acid; Suspensions; Thiazoles | 2012 |
Solid nanocrystalline dispersions of ziprasidone with enhanced bioavailability in the fasted state.
Topics: Absorption; Administration, Oral; Animals; Antipsychotic Agents; Biological Availability; Calorimetry, Differential Scanning; Capsules; Crystallization; Dogs; Fasting; Methylcellulose; Piperazines; Solubility; Thiazoles; Tissue Distribution; X-Ray Diffraction | 2012 |
A Combined Utilization of Plasdone-S630 and HPMCAS-HF in Ziprasidone Hydrochloride Solid Dispersion by Hot-Melt Extrusion to Enhance the Oral Bioavailability and No Food Effect.
Topics: Administration, Oral; Animals; Biological Availability; Dogs; Drug Combinations; Fasting; Methylcellulose; Pharmaceutic Aids; Piperazines; Povidone; Solubility; Spectroscopy, Fourier Transform Infrared; Thiazoles; X-Ray Diffraction | 2019 |